Viewing Study NCT01462656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-05-22 @ 4:05 AM
Study NCT ID: NCT01462656
Status: TERMINATED
Last Update Posted: 2016-11-25
First Post: 2011-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Risk of Urinary Retention With Retigabine
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti-epileptic drug View
None ezogabine View
None AED polytherapy View
None epilepsy View
None AED monotherapy View
None retigabine View
None urinary retention View